Test Price
2,800 AED✅ Home Collection Available
EXT1 Gene Exostoses, Multiple, Type 1 – Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
✓ DIAGNOSTIC CERTAINTY: 99.9% Sensitivity via ISO 9001:2015 Certified Next‑Generation Sequencing (Cert: INT/EGQ/2509DA/3139).
✓ VIP MOBILE PHLEBOTOMY: Temperature‑controlled cold‑chain home collection (8 AM‑11 PM) – paid service included.
✓ POST‑TEST GUIDANCE: Telephonic clinical interpretation by a DHA‑licensed Consultant Medical Geneticist.
✓ INSTANT INSURANCE CHECK: WhatsApp +971 54 548 8731 for direct billing verification.
Test Overview & Methodology
This test screens for pathogenic variants in the EXT1 gene associated with Hereditary Multiple Exostoses (Type 1), using advanced NGS technology to cover all coding exons and splice junctions. It confirms clinical diagnosis, guides surgical and dermatologic surveillance, and enables accurate genetic counselling for at‑risk families.
| Feature | DNA Labs UAE EXT1‑NGS Test | Closest Alternative (Routine Panel) |
|---|---|---|
| Precision | NGS – full gene sequencing + CNV detection | Targeted mutation analysis only |
| Method | Illumina® next‑generation sequencing with MLPA backup | Sanger sequencing of selected exons |
| Turnaround | 3‑4 weeks | 6‑8 weeks |
Physician Insight & Safety Protocols
Clinical Perspective – Lina Osama Zaki Quteineh (DHA License: 9294403):
“A positive EXT1 result does not define the disease severity; osteochondromas vary widely in location and growth velocity. Always correlate with imaging and physical examination. This test is a powerful tool for early surveillance, but it must be interpreted within the full family and clinical context to avoid unnecessary anxiety.”
Medical Advisory: Medication Continuity
Do not discontinue any prescribed medication without direct consultation with your treating physician. This genetic test does not alter current medical management unless specifically advised by your specialist.
Patient Safety – Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Recent blood transfusion (≤2 weeks) may compromise germline DNA integrity – reschedule accordingly.
- Active systemic infection requiring hospitalisation – postpone until clinical stability is achieved.
- Inability to provide informed consent (patient or legal guardian).
Seek Immediate Emergency Care
- Sudden, severe pain near a known osteochondroma.
- Rapid limb swelling.
- Neurological deficits (weakness or numbness) – may indicate malignant transformation or nerve compression.
Patient FAQ & Clinical Guidance
1. How accurate is the EXT1 NGS test for diagnosing hereditary multiple exostoses?
The test achieves 99.9% diagnostic sensitivity for detecting single‑nucleotide variants and copy‑number changes across the entire EXT1 gene, which is the gold standard for confirming molecular diagnosis of Type I exostoses.
2. How long does it take to receive EXT1 genetic test results?
The next‑generation sequencing process and comprehensive data analysis require 3 to 4 weeks. A free post‑test genetic counselling session is included upon report issuance.
3. Can I use a small blood spot (FTA card) instead of a full venipuncture?
Yes, a single drop of blood on an FTA card is an accepted specimen for EXT1 analysis, providing sufficient DNA for sequencing and meeting all DHA sample adequacy standards.
4. Will my insurance cover the EXT1 genetic test?
Coverage depends on your specific insurance provider and policy. You can instantly verify direct billing eligibility by contacting us via WhatsApp at +971 54 548 8731.
5. What happens if my EXT1 test result is positive?
A positive result confirms the genetic diagnosis of hereditary multiple exostoses Type 1. Our DHA‑licensed Consultant Medical Geneticist will provide a detailed interpretation during the post‑test counselling session, including familial risk assessment and surveillance recommendations.
UAE Regulatory & Data Privacy Adherence
Strict Compliance with UAE Data Protection Laws
All genetic data is processed and stored exclusively within the UAE, fully adhering to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow the guidelines of the Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | EXT1 Gene Exostoses, Multiple, Type 1 – Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) with MLPA |
| ICD-10-CM Code | Q78.6 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians